ICU sedation, delirium & recovery

Delirium During Critical Illness and Subsequent Change of Treatment in Patients With Cancer: A Mediation Analysis*

Crit Care MedPublished Retrospective cohort study

Main finding · Change in cancer treatment after dischargeResult — go to the resultAdjusted odds ratio 3.80 95% CI 2.72–5.35

Authors' conclusion

Patients who had delirium during ICU stay had a higher rate of modification of cancer treatment after discharge. The effect of delirium on change in cancer treatment was only partially mediated by the development of functional dependence after discharge. Change in cancer treatment was associated with increased 1-year mortality.

Study context

Population
Adults ≥18 years with a previous proposal of cancer treatment admitted to a 50-bed ICU in a dedicated cancer center
Participants
1,134 adults
Exposure
Delirium vs no delirium during ICU stay
  • Deliriumn = 189
Outcome
Change in cancer treatment after discharge
Methodological detailsmediation analysis, single-centre
  • Mediation analysis
  • Single-centre

Main finding

As reported in the abstract

Adjusted odds ratio

3.80

95% CI 2.72–5.35

Delirium vs No delirium
aOR 3.80 (95% CI 2.72–5.35)

Observational data: associations, not effects.

Further findings

OutcomeaOR (95% CI)
Mortality with change in treatment vs no change · 1 year2.68 (2.01–3.60)

Proportion of delirium effect on change of treatment mediated by functional dependence after discharge (mediation analysis)

Proportion mediated
33.0% (95% CI, 21.7-46.0%)
Association both direct and mediated by functional dependence after discharge

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Delirium During Critical Illness and Subsequent Change of Treatment in Patients With Cancer: A Mediation Analysis*. Crit Care Med. Published 19 October 2023. doi:10.1097/ccm.0000000000006070

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.